Estudio de lenvatinib en combinación con pembrolizumab frente al estándar de atención en participantes con cáncer colorrectal metastásico
The purpose of this study is to assess the safety and efficacy of lenvatinib (MK-7902/E7080) in combination with pembrolizumab (MK-3475) in participants with metastatic colorectal cancer. The study will also compare